UA49792C2 - ДИМЕТИЛБЕНЗОФУРАНИ ТА ДИМЕТИЛБЕНЗОПІРАНИ ЯК 5-НТ<sub>3</sub>-АНТАГОНІСТИ, СПОСОБИ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ - Google Patents

ДИМЕТИЛБЕНЗОФУРАНИ ТА ДИМЕТИЛБЕНЗОПІРАНИ ЯК 5-НТ<sub>3</sub>-АНТАГОНІСТИ, СПОСОБИ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ Download PDF

Info

Publication number
UA49792C2
UA49792C2 UA95048357A UA95048357A UA49792C2 UA 49792 C2 UA49792 C2 UA 49792C2 UA 95048357 A UA95048357 A UA 95048357A UA 95048357 A UA95048357 A UA 95048357A UA 49792 C2 UA49792 C2 UA 49792C2
Authority
UA
Ukraine
Prior art keywords
formulas
group
methoxy
amino
acid
Prior art date
Application number
UA95048357A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Деле Жорж Анрі Поль Ван
Жан-Поль Рене Марі Андре Босманс
Жан-Поль Рене Мари Андре Босманс
Лерховен Віллі Жоан Каролус Ван
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of UA49792C2 publication Critical patent/UA49792C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Addiction (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Dental Preparations (AREA)
UA95048357A 1992-11-20 1993-11-15 ДИМЕТИЛБЕНЗОФУРАНИ ТА ДИМЕТИЛБЕНЗОПІРАНИ ЯК 5-НТ<sub>3</sub>-АНТАГОНІСТИ, СПОСОБИ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ UA49792C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97901392A 1992-11-20 1992-11-20
PCT/EP1993/003206 WO1994012494A1 (en) 1992-11-20 1993-11-15 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists

Publications (1)

Publication Number Publication Date
UA49792C2 true UA49792C2 (uk) 2002-10-15

Family

ID=25526607

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95048357A UA49792C2 (uk) 1992-11-20 1993-11-15 ДИМЕТИЛБЕНЗОФУРАНИ ТА ДИМЕТИЛБЕНЗОПІРАНИ ЯК 5-НТ<sub>3</sub>-АНТАГОНІСТИ, СПОСОБИ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ

Country Status (31)

Country Link
US (2) US5674868A (OSRAM)
EP (1) EP0669919B1 (OSRAM)
JP (1) JP2830952B2 (OSRAM)
KR (1) KR0166661B1 (OSRAM)
AT (1) ATE176232T1 (OSRAM)
AU (1) AU680640B2 (OSRAM)
BG (1) BG62489B1 (OSRAM)
BR (1) BR9307477A (OSRAM)
CA (1) CA2149044C (OSRAM)
CZ (1) CZ287262B6 (OSRAM)
DE (1) DE69323322T2 (OSRAM)
DK (1) DK0669919T3 (OSRAM)
ES (1) ES2129615T3 (OSRAM)
FI (1) FI952458A7 (OSRAM)
GR (1) GR3029831T3 (OSRAM)
HU (2) HUT72740A (OSRAM)
IL (3) IL119273A0 (OSRAM)
LV (1) LV10956B (OSRAM)
MX (1) MX9307257A (OSRAM)
NO (2) NO307690B1 (OSRAM)
NZ (1) NZ257854A (OSRAM)
OA (1) OA10158A (OSRAM)
PL (1) PL176051B1 (OSRAM)
RO (1) RO115160B1 (OSRAM)
RU (1) RU2116072C1 (OSRAM)
SG (1) SG47488A1 (OSRAM)
SK (1) SK282378B6 (OSRAM)
TW (1) TW294595B (OSRAM)
UA (1) UA49792C2 (OSRAM)
WO (1) WO1994012494A1 (OSRAM)
ZA (1) ZA938676B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
PT975327E (pt) * 1997-04-18 2003-11-28 Janssen Pharmaceutica Nv Uso de antagonistas de 5ht3 para estimular a lavagem intestinal
WO1999002496A1 (en) * 1997-07-11 1999-01-21 Janssen Pharmaceutica N.V. (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
US6239122B1 (en) * 2000-01-05 2001-05-29 Joy Ann Steele Method of treatment of nausea, vomiting, and other disorders using estrogens
ATE440825T1 (de) * 2003-06-06 2009-09-15 Vertex Pharma Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
MXPA06005687A (es) 2003-11-20 2006-08-17 Janssen Pharmaceutica Nv 2-quinolinonas y 2-quinoxalinonas sustituidas con 6-alquenilo y 6-fenilalquilo como inhibidores de la poli(adenosin fosfato-ribosa)polimerasa.
EA011211B1 (ru) 2003-11-20 2009-02-27 Янссен Фармацевтика Н. В. 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы
AU2005259189B2 (en) 2004-06-30 2011-04-21 Janssen Pharmaceutica N.V. Phthalazine derivatives as PARP inhibitors
AU2005259192C1 (en) * 2004-06-30 2012-03-01 Janssen Pharmaceutica N.V. Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
SG154432A1 (en) 2004-06-30 2009-08-28 Janssen Pharmaceutica Nv Quinazolinedione derivatives as parp inhibitors
WO2008107478A1 (en) 2007-03-08 2008-09-12 Janssen Pharmaceutica Nv Quinolinone derivatives as parp and tank inhibitors
ES2448870T3 (es) 2007-10-26 2014-03-17 Janssen Pharmaceutica, N.V. Derivados de quinolina como inhibidores de PARP
JP5492183B2 (ja) 2008-03-27 2014-05-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｐａｒｐおよびチューブリン重合阻害剤としてのテトラヒドロフェナントリジノンおよびテトラヒドロシクロペンタキノリノン
EP2260026B1 (en) 2008-03-27 2011-06-22 Janssen Pharmaceutica, N.V. Quinazolinone derivatives as tubulin polymerization inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
ZW12187A1 (en) * 1986-07-03 1989-02-01 Janssen Pharmaceutica Nv 4-(aroylamino)piperidinebutanamide derivatives
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
US4914207A (en) * 1989-05-09 1990-04-03 Pfizer Inc. Arylthiazolylimidazoles
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives

Also Published As

Publication number Publication date
HU9501476D0 (en) 1995-07-28
NO308530B1 (no) 2000-09-25
ES2129615T3 (es) 1999-06-16
AU5465994A (en) 1994-06-22
NO995762D0 (no) 1999-11-24
ZA938676B (en) 1995-05-19
NO307690B1 (no) 2000-05-15
SK67595A3 (en) 1995-11-08
DE69323322D1 (de) 1999-03-11
NO951980D0 (no) 1995-05-19
ATE176232T1 (de) 1999-02-15
DK0669919T3 (da) 1999-09-13
BR9307477A (pt) 1999-06-29
EP0669919A1 (en) 1995-09-06
BG99593A (en) 1995-12-29
IL107654A (en) 1998-01-04
IL119273A0 (en) 1996-12-05
EP0669919B1 (en) 1999-01-27
IL119273A (en) 2000-07-16
NO951980L (no) 1995-05-19
GR3029831T3 (en) 1999-06-30
IL107654A0 (en) 1994-02-27
SK282378B6 (sk) 2002-01-07
WO1994012494A1 (en) 1994-06-09
NO995762L (no) 1995-05-19
RU95113434A (ru) 1997-03-10
AU680640B2 (en) 1997-08-07
CZ125895A3 (en) 1995-10-18
PL176051B1 (pl) 1999-03-31
NZ257854A (en) 1997-04-24
RU2116072C1 (ru) 1998-07-27
HUT72740A (en) 1996-05-28
HU211546A9 (en) 1995-12-28
FI952458L (fi) 1995-05-19
OA10158A (en) 1996-12-18
LV10956A (lv) 1995-12-20
CA2149044C (en) 2007-04-03
FI952458A0 (fi) 1995-05-19
US5674868A (en) 1997-10-07
SG47488A1 (en) 1998-04-17
KR0166661B1 (ko) 1999-01-15
CZ287262B6 (en) 2000-10-11
LV10956B (en) 1996-10-20
CA2149044A1 (en) 1994-06-09
US5863923A (en) 1999-01-26
BG62489B1 (bg) 1999-12-30
JP2830952B2 (ja) 1998-12-02
FI952458A7 (fi) 1995-05-19
MX9307257A (es) 1994-05-31
RO115160B1 (ro) 1999-11-30
DE69323322T2 (de) 1999-09-09
TW294595B (OSRAM) 1997-01-01
JPH08505840A (ja) 1996-06-25
PL309045A1 (en) 1995-09-18

Similar Documents

Publication Publication Date Title
DK2038268T3 (en) Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
UA49792C2 (uk) ДИМЕТИЛБЕНЗОФУРАНИ ТА ДИМЕТИЛБЕНЗОПІРАНИ ЯК 5-НТ&lt;sub&gt;3&lt;/sub&gt;-АНТАГОНІСТИ, СПОСОБИ ЇХ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
UA44691C2 (uk) Похідні оксазолідин-2-ону та лікарський засіб на їх основі
KR101449348B1 (ko) Ｋｖ７ 칼륨 채널 개방제로서의 피페리디닐 피리미딘 아미드
US20040068109A1 (en) Diazepan derivatives or salts thereof
FR2581993A1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
RU2392269C2 (ru) Производные арилоксиалкилкарбаматов, их получение и их применение в терапии
TWI322143B (en) Carboxamide derivatives as muscarinic receptor antagonists
JPH06500076A (ja) ピペリジン化合物、その合成およびその使用方法
JPH0660138B2 (ja) ジ−及びテトラ−ヒドロナフタレン類，その製法及びそれを含む医薬組成物
JP2009541251A (ja) 置換フェニルメタノン誘導体
RU2102392C1 (ru) Пиперидилметилзамещенные производные хромана и их соли с неорганическими кислотами
US5252578A (en) 3-aminochroman compounds
FI94863C (fi) Menetelmä terapeuttisesti käyttökelpoisten halogeeni-3,4-dihydro-bentsotiopyranyyliamiinien valmistamiseksi
EP0745591B1 (en) Indanylpiperidines as melatonergic agents
US4810792A (en) Piperidine intermediates
IE58121B1 (en) 1,3-Disubstituted piperdine compounds as neuroleptic agents
JP2002363163A (ja) ベンズアゼピン誘導体
EP0097628B1 (en) Piperidine derivatives, processes for their preparation and pharmaceutical preparation containing them
EP0739881A2 (en) Piperidine derivatives
JP2001512491A (ja) １−（イソキノリン−１−イル）−４−（１−フェニメチル）ピペラジン；ドーパミン受容体サブタイプ特異的リガンド
US4788201A (en) 3-methylenespiro (benzofuranpiperidines)
US4285938A (en) 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
JP2008527016A (ja) 神経及び神経精神病の疾患の治療のためのグリシントランスポーター１（ＧｌｙＴ−１）阻害剤としての２，５−二置換フェニルメタノン誘導体
PT94950A (pt) Processo para a preparacao de derivados benzopiranos